Commodore Capital’s Cogent Biosciences COGT Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q3 | $104M | Buy |
|
|||||
|
2025
Q2 | $16.6M | Sell |
|
|||||
|
2025
Q1 | $53.3M | Buy |
|
|||||
|
2024
Q4 | $53.7M | Sell |
|
|||||
|
2024
Q3 | $81.4M | Sell |
|
|||||
|
2024
Q2 | $82.1M | Buy |
|
|||||
|
2024
Q1 | $43.2M | Buy |
|
|||||
|
2023
Q4 | $32.7M | Hold |
|
|||||
|
2023
Q3 | $54.3M | Hold |
|
|||||
|
2023
Q2 | $65.9M | Buy |
|
|||||
|
2023
Q1 | $51.5M | Buy |
|
|||||
|
2022
Q4 | $49.9M | Hold |
|
|||||
|
2022
Q3 | $64.5M | Sell |
|
|||||
|
2022
Q2 | $44.6M | Buy |
|
|||||
|
2022
Q1 | $26.2M | Buy |
|
|||||
|
2021
Q4 | $19.6M | Buy |
|
|||||
|
2021
Q3 | $16.1M | Buy |
|
|||||
|
2021
Q2 | $11.1M | Buy |
|
|||||
|
2021
Q1 | $11.1M | Buy |
|
|||||
|
2020
Q4 | $8.54M | Buy |
|